Study Shows ObamaCare Will Dramatically Increase Healthcare Costs for Businesses

As the Obama administration continues to field criticisms over the disastrous last day for healthcare enrollment on the government website, a new survey relays details that are sure to cause further trouble for ObamaCare advocates.

According to the survey by the American Health Policy Institute, the cost of the new healthcare law for large companies ranges from $4,800 to $5,900 per employee, in addition to the millions of dollars in overhead costs. The healthcare law adds mandates and fees and other regulatory burdens that will cost employers anywhere from $163 million and $200 million in 2016, four percent more than what they are currently paying. By 2023, that increase will jump to eight percent.

The Washington Free Beacon reports, “The American Health Policy Institute conducted a confidential survey of 100 large employers — those with 10,000 or more employees — asking what costs they expect to incur from Obamacare over the next decade.”

“This study is a c-suite diagnosis of how [the Affordable Care Act] is shaping large employer behavior,” said Tevi Troy, president of the American Health Policy Institute. “We don’t know yet precisely how employers will react, but the study shows that employers will have to make real changes or incur heavy costs, which means that the ACA will have a significant impact on those in employer-sponsored healthcare.”

The study concludes that these increases could determine how employers provide healthcare for their employees, maybe even prompting some companies not to do so.

This is just one of a number of studies that have found that ObamaCare is increasing the financial burdens of businesses.

A report by the Urban Institute determined that ObamaCare raised healthcare costs for large companies by $11.8 billion in 2012. Likewise, the Joint Committee on Taxation estimated that the excise tax on high cost plans would cost $32 billion between 2018 and 2019.

But the American Health Policy Institute’s study was the first to ask companies directly what their new costs would be as a result of ObamaCare.